A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery.
Yacoub
M H
MH
Heart Science Centre, Royal Brompton and Harefield Hospital, Harefield, Middlesex, UK.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery*; D006353:Heart-Assist Devices; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods; D018342:Receptors, Adrenergic, beta-1 / Q000187:drug effects; D016896:Treatment Outcome; D020257:Ventricular Remodeling / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D018342:Receptors, Adrenergic, beta-1